Fund Development Committee
The Fund Development Committee (FDC): defines the annual and long-term funding needs of the organization, including the development of all funding sources (e.g. Industry Partnership Program, Partner Circle Program, Annual Conferences); establishes fundraising performance goals and major strategies to reach those goals and annual targets; and determines budgets, pricing, and fees for meetings, conferences, and other programs based.
Charlotte Kremer
(Chair)
EVP and Head of Medical Affairs, Astellas Pharma
Andy Greenspan
(Fund Development Committee Member)
VP, Medical Affairs, Immunology, Janssen
Meg Heim
(Innovative Revenue Streams Subcommittee Chair)
Global Healthcare Executive-Multinational Global Medical Affairs Leadership
Jan Schadrack
(Fund Development Committee Member)
Global TA Head Neuroscience & Rare Diseases, Medical, Roche
Anna Walz
(Partner Circle Program Subcommittee Chair)
Founder & CEO Emeritus, MedEvoke & Senior Strategic Advisor at MEDISTRAVA
